Cyclophosphamide

CAS 50-18-0 13 current records 4 historicalSmall Molecule

Who holds supplier records for Cyclophosphamide? 13 organisations hold a current record for Cyclophosphamide: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (3), United States (3) and Taiwan (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cyclophosphamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cyclophosphamide

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Cyclophosphamide expires 15 Feb 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cyclophosphamide. Country is the organisation's recorded country, not necessarily the manufacturing site.

India5China3United States3Taiwan1Country not recorded for 1
Need Cyclophosphamide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Cyclophosphamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
CEP 2025-325 - Rev 00
Cyclophosphamide monohydrate
Nov 2025—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2020-083 - Rev 03
Cyclophosphamide monohydrate
Oct 2025—
HETERO LABS LIMITED HyderabadIN
CEP 2014-342 - Rev 02
Cyclophosphamide monohydrate
Aug 2025—
MSN LABORATORIES PRIVATE LIMITED Kardanur VillageIN
CEP 2018-092 - Rev 02
Cyclophosphamide monohydrate, Milled and non milled
Jan 2025Inspected Aug 2026
Slovakia
ANHUI POLY PHARM. CO., LTD. AnqingCN
CEP 2022-356 - Rev 01
Cyclophosphamide monohydrate
Nov 2024—
EMCURE PHARMACEUTICALS LIMITED PuneIN
R1-CEP 2010-329 - Rev 02
Cyclophosphamide monohydrate
Aug 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Cyclophosphamide are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • OLAINFARM JOINT STOCK CO
    Inactive DMF 17065 · filed Dec 2003
  • DEGUSSA HULS AG
    Inactive DMF 14830 · filed Apr 2000
  • LIANYUNGANG PHARMACEUTICAL FACTORY
    Inactive DMF 13050 · filed Jul 1998
  • PHARM ECO LABORATORIES INC
    Inactive DMF 6398 · filed Aug 1985

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (59 listed products contain Cyclophosphamide). The latest listed patent expires 15 Feb 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Cyclophosphamide is an alkylating agent used in the treatment of various types of cancer and certain autoimmune diseases. It works by interfering with the growth and replication of cancer cells.

Chemical identity

IUPAC name
N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine;hydrate
Canonical SMILES
C1CNP(=O)(OC1)N(CCCl)CCCl.O
InChIKey
PWOQRKCAHTVFLB-UHFFFAOYSA-N
Synonyms
Cytoxan API, b-518, ciclofosfamide, cycloblastin, cyclophosphamide hydrate, cyclophosphamide monohydrate, cyclophosphamidum, cyclophosphanum, cyclostin, cytophosphan, cytophosphane, cytoxan

Therapeutic areas

OncologyRheumatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cyclophosphamide?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Cyclophosphamide: AARTI PHARMALABS LIMITED (India), ANHUI POLY PHARM CO LTD (China), Emcure Pharmaceuticals Limited (India), Hetero Labs Limited (India), MSN Laboratories Private Limited (India), SHILPA PHARMA LIFESCIENCES LTD (India), Ampac Fine Chemicals (United States) and APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cyclophosphamide Drug Master Files are active?

AARTI PHARMALABS LIMITED (DMF 35313, 37086), ANHUI POLY PHARM CO LTD (DMF 37154), Emcure Pharmaceuticals Limited (DMF 22794, 29839), Hetero Labs Limited (DMF 26753), MSN Laboratories Private Limited (DMF 31088), SHILPA PHARMA LIFESCIENCES LTD (DMF 34066), Ampac Fine Chemicals (DMF 32492) and APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC) (DMF 36089) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cyclophosphamide records mean?

4 organisations have only inactive Type II DMFs for Cyclophosphamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cyclophosphamide have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Cyclophosphamide on the EDQM register, including AARTI PHARMALABS LIMITED Mulund (W), Mumbai (IN), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), HETERO LABS LIMITED Hyderabad (IN), MSN LABORATORIES PRIVATE LIMITED Kardanur Village (IN), ANHUI POLY PHARM. CO., LTD. Anqing (CN) and EMCURE PHARMACEUTICALS LIMITED Pune (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Cyclophosphamide?

Yes. The latest patent listed for an approved US product containing Cyclophosphamide expires 15 Feb 2036, across 59 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Cyclophosphamide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cyclophosphamide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.